Article: New RAD51 Inhibitors to Target Homologous Recombination in Human Cells
Genes. 2021 June 16, v. 12, no. 6
2021
Abstract: Targeting DNA repair proteins with small-molecule inhibitors became a proven anti-cancer strategy. Previously, we identified an inhibitor of a major protein of homologous recombination (HR) RAD51, named B02. B02 inhibited HR in human cells and sensitized ...
Abstract | Targeting DNA repair proteins with small-molecule inhibitors became a proven anti-cancer strategy. Previously, we identified an inhibitor of a major protein of homologous recombination (HR) RAD51, named B02. B02 inhibited HR in human cells and sensitized them to chemotherapeutic drugs in vitro and in vivo. Here, using a medicinal chemistry approach, we aimed to improve the potency of B02. We identified the B02 analog, B02-isomer, which inhibits HR in human cells with significantly higher efficiency. We also show that B02-iso sensitizes triple-negative breast cancer MDA-MB-231 cells to the PARP inhibitor (PARPi) olaparib. |
---|---|
Keywords | DNA repair ; breast neoplasms ; chemistry ; drug therapy ; homologous recombination ; humans |
Language | English |
Dates of publication | 2021-0616 |
Publishing place | Multidisciplinary Digital Publishing Institute |
Document type | Article |
ZDB-ID | 2527218-4 |
ISSN | 2073-4425 |
ISSN | 2073-4425 |
DOI | 10.3390/genes12060920 |
Database | NAL-Catalogue (AGRICOLA) |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.